Tag: lifts

  • GSK lifts annual forecasts again, powered by strong vaccine launch

    By Eva Mathews (Reuters) -GSK raised its full-year profit and sales forecasts for a second time on Wednesday, following the strong launch of its respiratory syncytial virus (RSV) vaccine in the United States. GSK is betting on RSV vaccine Arexvy to be its next blockbuster medicine as it grapples with a combination of patent expiries…